متابعة
Daniel Merk
Daniel Merk
ETH Zurich, Switzerland; Goethe University Frankfurt, Germany
بريد إلكتروني تم التحقق منه على pharmchem.uni-frankfurt.de
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Polypharmacology by design: a medicinal chemist’s perspective on multitargeting compounds
E Proschak, H Stark, D Merk
Journal of medicinal chemistry 62 (2), 420-444, 2018
4532018
De Novo Design of Bioactive Small Molecules by Artificial Intelligence
D Merk, L Friedrich, F Grisoni, G Schneider
Molecular informatics 37 (1-2), 1700153, 2018
3942018
Generative molecular design in low data regimes
M Moret, L Friedrich, F Grisoni, D Merk, G Schneider
Nature Machine Intelligence 2 (3), 171-180, 2020
1842020
Combining generative artificial intelligence and on-chip synthesis for de novo drug design
F Grisoni, BJH Huisman, AL Button, M Moret, K Atz, D Merk, G Schneider
Science Advances 7 (24), eabg3338, 2021
1332021
The medicinal chemistry of caffeine
G Faudone, S Arifi, D Merk
Journal of medicinal chemistry 64 (11), 7156-7178, 2021
1182021
Tuning artificial intelligence on the de novo design of natural-product-inspired retinoid X receptor modulators
D Merk, F Grisoni, L Friedrich, G Schneider
Communications Chemistry 1 (1), 68, 2018
1072018
Automated de novo molecular design by hybrid machine intelligence and rule-driven chemical synthesis
A Button, D Merk, JA Hiss, G Schneider
Nature machine intelligence 1 (7), 307-315, 2019
992019
Opportunities and challenges for fatty acid mimetics in drug discovery
E Proschak, P Heitel, L Kalinowsky, D Merk
Journal of medicinal chemistry 60 (13), 5235-5266, 2017
942017
A dual modulator of farnesoid X receptor and soluble epoxide hydrolase to counter nonalcoholic steatohepatitis
J Schmidt, M Rotter, T Weiser, S Wittmann, L Weizel, A Kaiser, J Heering, ...
Journal of medicinal chemistry 60 (18), 7703-7724, 2017
862017
Molecular tuning of farnesoid X receptor partial agonism
D Merk, S Sreeramulu, D Kudlinzki, K Saxena, V Linhard, SL Gande, ...
Nature communications 10 (1), 2915, 2019
832019
Nonacidic farnesoid X receptor modulators
D Flesch, SY Cheung, J Schmidt, M Gabler, P Heitel, J Kramer, A Kaiser, ...
Journal of Medicinal Chemistry 60 (16), 7199-7205, 2017
822017
Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008–present)
C Lamers, M Schubert-Zsilavecz, D Merk
Expert opinion on therapeutic patents 22 (7), 803-841, 2012
802012
Scaffold hopping from natural products to synthetic mimetics by holistic molecular similarity
F Grisoni, D Merk, V Consonni, JA Hiss, SG Tagliabue, R Todeschini, ...
Communications Chemistry 1 (1), 44, 2018
712018
Beam search for automated design and scoring of novel ROR ligands with machine intelligence
M Moret, M Helmstädter, F Grisoni, G Schneider, D Merk
Angewandte Chemie International Edition 60 (35), 19477-19482, 2021
682021
Small molecules with anti-inflammatory properties in clinical development
T Hanke, D Merk, D Steinhilber, G Geisslinger, M Schubert-Zsilavecz
Pharmacology & therapeutics 157, 163-187, 2016
662016
Target 2035–update on the quest for a probe for every protein
S Müller, S Ackloo, A Al Chawaf, B Al-Lazikani, A Antolin, JB Baell, ...
RSC Medicinal Chemistry 13 (1), 13-21, 2022
642022
Extending the structure–activity relationship of anthranilic acid derivatives as Farnesoid X receptor modulators: Development of a highly potent partial Farnesoid X receptor …
D Merk, C Lamers, K Ahmad, R Carrasco Gomez, G Schneider, ...
Journal of Medicinal Chemistry 57 (19), 8035-8055, 2014
632014
Medicinal chemistry of farnesoid X receptor ligands: from agonists and antagonists to modulators
D Merk, D Steinhilber, M Schubert-Zsilavecz
Future medicinal chemistry 4 (8), 1015-1036, 2012
572012
N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ Modulators
R Blöcher, C Lamers, SK Wittmann, D Merk, M Hartmann, L Weizel, ...
Journal of medicinal chemistry 59 (1), 61-81, 2016
562016
NSAIDs Ibuprofen, Indometacin and Diclofenac do not interact with Farnesoid X Receptor
J Schmidt, FM Klingler, E Proschak, D Steinhilber, M Schubert-Zsilavecz, ...
Scientific reports 5 (1), 1-12, 2015
532015
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20